Collaborations

Our innovative technology platforms have led to collaborations with leading pharmaceutical companies:

• Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases.

• Collaboration with Pfizer Inc. in the field of cancer target discovery.

• Collaboration with Merck Serono for the generation of monoclonal antibodies to be used in the search for molecular biomarkers.

• Collaboration with MedImmune on Encoded Self-Assembling Chemical Libraries

For additional information about partnering opportunities, please contact:

Dr. Jane Wilton, Director of Business Development

Email: jane.wilton@philogen.it